首页|期刊导航|肿瘤预防与治疗|胃腺癌伴神经内分泌分化的研究进展

胃腺癌伴神经内分泌分化的研究进展OA

Research Progress on Gastric Adenocarcinoma with Neuroendocrine Dif-ferentiation

中文摘要英文摘要

胃癌是常见的消化系统恶性肿瘤之一,具有显著的生物学异质性.其中,绝大多数胃癌为胃腺癌,是胃癌研究和临床诊疗中的主要病理类型.随着免疫组织化学及分子病理技术的发展,胃腺癌中"隐藏"的神经内分泌分化逐渐受到关注,并被认为可形成一种特殊的病理表型,即胃腺癌伴神经内分泌分化.该表型在保留腺癌基本组织学特征的同时,可表达突触素、嗜铬粒蛋白 A 等神经内分泌标志物,并可能与更强侵袭性、不良预后及治疗反应差异相关.近年来,围绕其病理诊断、临床病理特征、预后价值及治疗策略的研究逐渐增多,但其诊断标准和临床意义尚未形成统一共识.本文系统梳理了胃腺癌伴神经内分泌分化的研究进展,并对其潜在临床价值进行总结与展望.

Gastric cancer is one of the most common malignancies of the digestive system and exhibits marked biological heterogeneity.Among gastric cancers,the vast majority are gastric adenocarcinomas,which represent the predominant histo-logical type in gastric cancer research and clinical practice.With advances in immunohistochemistry and molecular patholo-gy,"hidden"neuroendocrine differentiation in gastric adenocarcinoma has received increasing attention and is considered to represent a distinct pathological phenotype,namely gastric adenocarcinoma with neuroendocrine differentiation(GC-NED).While retaining the basic histological features of adenocarcinoma,this phenotype can express neuroendocrine markers such as synaptophysin and chromogranin A,and may be associated with greater invasiveness,poorer prognosis,and differences in treatment response.In recent years,studies on its pathological diagnosis,clinicopathological characteristics,prognostic val-ue,and therapeutic strategies have increased,but its diagnostic criteria and clinical significance remain inconclusive.This review systematically summarizes the research progress on GC-NED and discusses its potential clinical value and future per-spectives.

肖鹂瑶;李蓉;詹晨阳;潜均仪;胡凤娣

650118 昆明,昆明医科大学第三附属医院/云南省肿瘤医院/北京大学肿瘤医院云南医院 消化肿瘤内科650118 昆明,昆明医科大学第三附属医院/云南省肿瘤医院/北京大学肿瘤医院云南医院 消化肿瘤内科650118 昆明,昆明医科大学第三附属医院/云南省肿瘤医院/北京大学肿瘤医院云南医院 病理科650118 昆明,昆明医科大学第三附属医院/云南省肿瘤医院/北京大学肿瘤医院云南医院 消化肿瘤内科650118 昆明,昆明医科大学第三附属医院/云南省肿瘤医院/北京大学肿瘤医院云南医院 消化肿瘤内科

医药卫生

胃腺癌神经内分泌分化病理特征临床预后治疗策略文献综述

AdenocarcinomaNeuroendocrine differentia-tionPathological featuresClinical prognosisTreatment strategiesLiterature review

《肿瘤预防与治疗》 2026 (9)

799-805,7

This study was supported by grants from Yunnan Cancer Hospital(No.CZ01972024B3)and Kunming Medical University(No.QL-JBGS-09). 云南省肿瘤医院消化内科省级临床重点专科建设项目(编号:CZ01972024B3)昆明医科大学领研临床科研项目(编号:QL-JBGS-09)

10.3969/j.issn.1674-0904.2026.09.010

评论